Shareholding disclosure

Cytos Biotechnology AG

Declared position

21.47%

Threshold

Crossed downwards

Timeline

Published

22.06.2010

Transaction

17.06.2010

Transfer date

17.06.2010

Voting rights breakdown

Voting rights acquired3.13%

Voting rights sold21.47%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAA6I00036

Beneficial owner

Cytos Biotechnology AG

Declared address

Cytos Biotechnology AG, 8952 Schlieren

Überschreitung der 3% Schwelle infolge weiterer Teilrückkäufe der eigenen Wandelanleihe

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cytos Biotechnology AG

Kuros Biosciences AG22.06.2010TAA6I00036

Disclosure summary

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG on the disposal side, published by SIX Exchange Regulation on 22.06.2010, at 21.47% of voting rights. Notice category: Single shareholder.

Disclosed position

21.47%

Voting rights sold

Voting rights acquired3.13%

Voting rights sold21.47%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cytos Biotechnology AG disclosed a holding in Kuros Biosciences AG, published on 22.06.2010.

Publication date22.06.2010

Transaction date17.06.2010

Transfer date17.06.2010

Issuing companyKuros Biosciences AG

Beneficial ownerCytos Biotechnology AG

Declared addressCytos Biotechnology AG, 8952 Schlieren

CategorySingle shareholder

Voting rights acquired3.13%

Voting rights sold21.47%

Below threshold0%

ExchangeXSWX

Notification IDTAA6I00036

Commercial register

CHE-104.785.642

Registered

Zefix record

Conditions

Überschreitung der 3% Schwelle infolge weiterer Teilrückkäufe der eigenen Wandelanleihe

Source: SIX Exchange Regulation · Publication date: 22.06.2010

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open